Susquehanna Fundamental Investments’s Olema Pharmaceuticals OLMA Stock Holding History

Susquehanna Fundamental Investments’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-94,883	Closed	-$2.37M	–	638
2025 Q4	$2.37M	Hold	94,883	–	–	0.08%	231
2025 Q3	$929K	Sell	94,883 -18,609	-16%	-$112K	0.04%	345
2025 Q2	$483K	Sell	113,492 -61,956	-35%	-$276K	0.01%	555
2025 Q1	$660K	Buy	175,448 +164,472	+1,498%	+$827K	0.01%	785
2024 Q4	$64K	Buy	+10,976	New	+$110K	﹤0.01%	1055
2024 Q2	–	Sell	-15,565	Closed	-$176K	–	994
2024 Q1	$176K	Buy	+15,565	New	+$201K	0.01%	629

Other funds holding OLMA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Susquehanna Fundamental Investments's OLMA Position: Q1 2026 in Review

Susquehanna Fundamental Investments sold out of Olema Pharmaceuticals (OLMA) in Q1 2026, closing a stake of 94,883 shares — an estimated $2.37M sold.

Susquehanna Fundamental Investments first reported a position in OLMA in Q1 2024 and held it in 6 quarters. The position peaked at $2.37M in Q4 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

Susquehanna Fundamental Investments reported no remaining Olema Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Susquehanna Fundamental Investments sold 94,883 Olema Pharmaceuticals shares in Q1 2026, an estimated $2.37M.
Susquehanna Fundamental Investments first reported a position in Olema Pharmaceuticals in Q1 2024 and held it in 6 quarters.
Susquehanna Fundamental Investments's Olema Pharmaceuticals position peaked at $2.37M in Q4 2025.
195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2026, filed 15 May 2026.